ATE299183T1 - Apoptose induzierende proteinesubstanz - Google Patents

Apoptose induzierende proteinesubstanz

Info

Publication number
ATE299183T1
ATE299183T1 AT00978103T AT00978103T ATE299183T1 AT E299183 T1 ATE299183 T1 AT E299183T1 AT 00978103 T AT00978103 T AT 00978103T AT 00978103 T AT00978103 T AT 00978103T AT E299183 T1 ATE299183 T1 AT E299183T1
Authority
AT
Austria
Prior art keywords
apoptosis
inducing protein
protein substance
novel therapeutic
apoptin
Prior art date
Application number
AT00978103T
Other languages
English (en)
Inventor
Mathieu Hubertus Mari Noteborn
Bertram Weiss
Original Assignee
Leadd Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leadd Bv filed Critical Leadd Bv
Application granted granted Critical
Publication of ATE299183T1 publication Critical patent/ATE299183T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT00978103T 1999-10-21 2000-10-20 Apoptose induzierende proteinesubstanz ATE299183T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99203467A EP1094110A1 (de) 1999-10-21 1999-10-21 Proteinsubstanz das Apoptose induziert
PCT/NL2000/000767 WO2001029226A2 (en) 1999-10-21 2000-10-20 Apoptosis inducing proteinaceous substance

Publications (1)

Publication Number Publication Date
ATE299183T1 true ATE299183T1 (de) 2005-07-15

Family

ID=8240768

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00978103T ATE299183T1 (de) 1999-10-21 2000-10-20 Apoptose induzierende proteinesubstanz

Country Status (6)

Country Link
US (1) US20030054994A1 (de)
EP (2) EP1094110A1 (de)
AT (1) ATE299183T1 (de)
AU (1) AU1559501A (de)
DE (1) DE60021196D1 (de)
WO (1) WO2001029226A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3199180B1 (de) 2007-03-08 2022-01-05 Humanigen, Inc. Ep ha3-antikörper zur behandlung von soliden tumoren
JP5639039B2 (ja) 2008-04-11 2014-12-10 メリマック ファーマシューティカルズ インコーポレーティッド ヒト血清アルブミンリンカーおよびそのコンジュゲート
WO2010056804A1 (en) 2008-11-12 2010-05-20 Medimmune, Llc Antibody formulation
CN102282168A (zh) 2008-11-18 2011-12-14 梅里麦克制药股份有限公司 人血清白蛋白接头以及其结合物
US8834870B2 (en) 2009-03-06 2014-09-16 Kalobios Pharmaceuticals, Inc. Treatment of leukemias and chronic myeloproliferative diseases with antibodies to EphA3
BRPI1015234A2 (en) 2009-06-22 2018-02-20 Medimmune Llc fc regions designed for site specific conjugation.
CN106620693A (zh) 2010-09-03 2017-05-10 艾伯维施特姆森特克斯有限责任公司 新型调节剂及使用方法
CN103429620B (zh) 2010-11-05 2018-03-06 酵活有限公司 在Fc结构域中具有突变的稳定异源二聚的抗体设计
EP4063391A1 (de) 2012-07-25 2022-09-28 Celldex Therapeutics, Inc. Anti-kit-antikörper und verwendungen davon
US9345766B2 (en) 2012-08-30 2016-05-24 Merrimack Pharmaceuticals, Inc. Combination therapies comprising anti-ERBB3 agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0924296A3 (de) * 1997-12-03 2001-08-01 Leadd B.V. Verfahren un Mittteln für die Induktion von Apoptosis durch Interferenz in RNS-Prozessierung
GB9930519D0 (en) * 1999-12-24 2000-02-16 Phogen Limited Uses of transport proteins

Also Published As

Publication number Publication date
EP1222280A2 (de) 2002-07-17
EP1094110A1 (de) 2001-04-25
US20030054994A1 (en) 2003-03-20
EP1222280B1 (de) 2005-07-06
WO2001029226A3 (en) 2002-02-07
WO2001029226A2 (en) 2001-04-26
DE60021196D1 (de) 2005-08-11
AU1559501A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
BR0009505A (pt) Compostos e processos para terapia e diagnóstico de câncer de pulmão
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
BR0209254A (pt) anticorpos de bloqueio cripto e usos dos mesmos
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
DE69731611D1 (de) Eine Zusammensetzung enthaltend eine Detergenz und einen ein Tumorsuppressorgen kodierenden, adenoviralen Vektor
WO2003074550A3 (en) Pin1-modulating compounds and methods of use thereof
BRPI0213223B8 (pt) polipeptídeo, dímero ou multímero, polinucleotídeo, vetor de expressão, célula hospedeira, composição farmacêutica, e, uso de uma composição
DE60021196D1 (de) Apoptose induzierende proteinesubstanz
NO20055838L (no) Aktive varianter av IL-18 bindende protein og medisinske anvendelser derav
NO20015516D0 (no) Preparater og anvendelser av ET743 for behandling av kreft
WO2005007123A3 (en) Pin1-modulating compounds and methods of use thereof
ATE247466T1 (de) Pharmazeutische zubereitungen enthaltend ibuprofen und domperidon zur behandlung von migräne
DE60109359D1 (de) Verwendung von anti-ferritin antikörper bei der behandlung von bestimmten krebsarten
DE69837148D1 (de) Chimäre proteine zur behandlung von diabetes
WO2001072824A3 (en) Apoptin-associating protein
DK1083224T3 (da) Apoptin-associerende protein
WO2001042461A3 (en) Apoptin-associating protein
DE60239864D1 (de) Kondensierte thiophene verbindungen und deren verwendung zur behandlung von chronischen schmerzen
ATE395935T1 (de) An der oberfläche von karzinomzellen lokalisiertes colligin/hsp47
WO2001053351A3 (en) Apoptin bindendes protein
EP1111045A3 (de) Apoptin-bindendes Protein
EP1138768A3 (de) Apoptin-bindendes Protein AAP-5
EP1118662A3 (de) Apoptin bindendes Protein
WO2003060067A3 (en) P85-alpha nucleic acids, polypeptides and related methods
WO2002079222A3 (en) Fusion proteins for specific treatment of cancer and auto-immune diseases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties